Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
NCT00304096
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
BIOLOGICAL:
synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine
Sponsor
University of Virginia
Collaborators
[object Object]